Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
Robert J. HombachDirector | Seaport TherapeuticsSPTX | Open-market buy | 06/22 | 06/24 | 13,000 sh | $18.14 | $235,820 | No record |
Keith Crandell10% Owner | Seaport TherapeuticsSPTX | Open-market buy | 05/04 | 05/04 | 1,100,000 sh | $18.00 | $19,800,000 | +21.2% |
Robert Nelsen10% Owner | Seaport TherapeuticsSPTX | Open-market buy | 05/04 | 05/04 | 1,100,000 sh | $18.00 | $19,800,000 | +21.2% |
Steven Gillis10% Owner | Seaport TherapeuticsSPTX | Open-market buy | 05/04 | 05/04 | 1,100,000 sh | $18.00 | $19,800,000 | +21.2% |
Kristina Burow10% Owner | Seaport TherapeuticsSPTX | Open-market buy | 05/04 | 05/04 | 1,100,000 sh | $18.00 | $19,800,000 | +21.2% |
Arch Venture Fund XII10% Owner | Seaport TherapeuticsSPTX | Open-market buy | 05/04 | 05/04 | 1,100,000 sh | $18.00 | $19,800,000 | +21.2% |
Arch Venture Partners XII10% Owner | Seaport TherapeuticsSPTX | Open-market buy | 05/04 | 05/04 | 1,100,000 sh | $18.00 | $19,800,000 | +21.2% |
Arch Venture Partners XII10% Owner | Seaport TherapeuticsSPTX | Open-market buy | 05/04 | 05/04 | 1,100,000 sh | $18.00 | $19,800,000 | +21.2% |